 | • レポートコード：GIR201106085 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、オピオイド薬の世界市場を調査対象にし、オピオイド薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（オキシコドン、ヒドロモルフォン、コデイン、フェンタニル、その他）、用途別分析（鎮痛、麻酔、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Teva、Pfizer、Amneal Pharma、Purdue Pharma、Endo、Mallinckrodt、Mylan、J&J、Collegium、INSYS、Hikma、Egalet ・メーカー別販売量、売上、市場シェア ・オピオイド薬の地域別市場分析 ・オピオイド薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・オピオイド薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・オピオイド薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・オピオイド薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・オピオイド薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・オピオイド薬の種類別市場規模2015-2020：オキシコドン、ヒドロモルフォン、コデイン、フェンタニル、その他 ・オピオイド薬の用途別市場規模2015-2020：鎮痛、麻酔、その他 ・オピオイド薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Opioids Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Opioids Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of -1.7%% in the forecast period of 2020 to 2025 and will expected to reach USD 10020 million by 2025, from USD 10740 million in 2019.
Market segmentation
Opioids Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Opioids Drug market has been segmented into
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
By Application, Opioids Drug has been segmented into:
Pain Relief
Anesthesia
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Opioids Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Opioids Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Opioids Drug market.
The report offers in-depth assessment of the growth and other aspects of the Opioids Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Opioids Drug Market Share Analysis
Opioids Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Opioids Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Opioids Drug sales, revenue and market share for each player covered in this report.
The major players covered in Opioids Drug are:
Teva
Pfizer
Amneal Pharma
Purdue Pharma
Endo
Mallinckrodt
Mylan
J&J
Collegium
INSYS
Hikma
Egalet
Among other players domestic and global, Opioids Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioids Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioids Drug, with price, sales, revenue and global market share of Opioids Drug in 2018 and 2019.
Chapter 3, the Opioids Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Opioids Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Opioids Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Opioids Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Opioids Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Opioids Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Other
1.4 Overview of Global Opioids Drug Market
1.4.1 Global Opioids Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva SWOT Analysis
2.1.4 Teva Product and Services
2.1.5 Teva Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amneal Pharma
2.3.1 Amneal Pharma Details
2.3.2 Amneal Pharma Major Business
2.3.3 Amneal Pharma SWOT Analysis
2.3.4 Amneal Pharma Product and Services
2.3.5 Amneal Pharma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Purdue Pharma
2.4.1 Purdue Pharma Details
2.4.2 Purdue Pharma Major Business
2.4.3 Purdue Pharma SWOT Analysis
2.4.4 Purdue Pharma Product and Services
2.4.5 Purdue Pharma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Endo
2.5.1 Endo Details
2.5.2 Endo Major Business
2.5.3 Endo SWOT Analysis
2.5.4 Endo Product and Services
2.5.5 Endo Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mallinckrodt
2.6.1 Mallinckrodt Details
2.6.2 Mallinckrodt Major Business
2.6.3 Mallinckrodt Product and Services
2.6.4 Mallinckrodt Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business
2.7.3 Mylan Product and Services
2.7.4 Mylan Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 J&J
2.8.1 J&J Details
2.8.2 J&J Major Business
2.8.3 J&J Product and Services
2.8.4 J&J Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Collegium
2.9.1 Collegium Details
2.9.2 Collegium Major Business
2.9.3 Collegium Product and Services
2.9.4 Collegium Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 INSYS
2.10.1 INSYS Details
2.10.2 INSYS Major Business
2.10.3 INSYS Product and Services
2.10.4 INSYS Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Hikma
2.11.1 Hikma Details
2.11.2 Hikma Major Business
2.11.3 Hikma Product and Services
2.11.4 Hikma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Egalet
2.12.1 Egalet Details
2.12.2 Egalet Major Business
2.12.3 Egalet Product and Services
2.12.4 Egalet Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Opioids Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Opioids Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Opioids Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Opioids Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Opioids Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Opioids Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Opioids Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Opioids Drug Sales and Growth Rate (2015-2020)
4.3 Europe Opioids Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Opioids Drug Sales and Growth Rate (2015-2020)
4.5 South America Opioids Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Opioids Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Opioids Drug Sales, Revenue and Market Share by Country
5.1.1 North America Opioids Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Opioids Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Opioids Drug Sales and Growth Rate (2015-2020)
5.3 Canada Opioids Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Opioids Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Opioids Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Opioids Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Opioids Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Opioids Drug Sales and Growth Rate (2015-2020)
6.3 UK Opioids Drug Sales and Growth Rate (2015-2020)
6.4 France Opioids Drug Sales and Growth Rate (2015-2020)
6.5 Russia Opioids Drug Sales and Growth Rate (2015-2020)
6.6 Italy Opioids Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Opioids Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Opioids Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Opioids Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Opioids Drug Sales and Growth Rate (2015-2020)
7.3 Japan Opioids Drug Sales and Growth Rate (2015-2020)
7.4 Korea Opioids Drug Sales and Growth Rate (2015-2020)
7.5 India Opioids Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Opioids Drug Sales and Growth Rate (2015-2020)
7.7 Australia Opioids Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Opioids Drug Sales, Revenue and Market Share by Country
8.1.1 South America Opioids Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Opioids Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Opioids Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Opioids Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Opioids Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Opioids Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Opioids Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Opioids Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Opioids Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Opioids Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Opioids Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Opioids Drug Sales and Market Share by Type (2015-2020)
10.2 Global Opioids Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Opioids Drug Price by Type (2015-2020)
11 Global Opioids Drug Market Segment by Application
11.1 Global Opioids Drug Sales Market Share by Application (2015-2020)
11.2 Global Opioids Drug Revenue Market Share by Application (2015-2020)
11.3 Global Opioids Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Opioids Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Opioids Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Opioids Drug Market Forecast (2021-2025)
12.2.2 Europe Opioids Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Opioids Drug Market Forecast (2021-2025)
12.2.4 South America Opioids Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Opioids Drug Market Forecast (2021-2025)
12.3 Opioids Drug Market Forecast by Type (2021-2025)
12.3.1 Global Opioids Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Opioids Drug Market Share Forecast by Type (2021-2025)
12.4 Opioids Drug Market Forecast by Application (2021-2025)
12.4.1 Global Opioids Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Opioids Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Opioids Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Opioids Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Opioids Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Opioids Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Teva Basic Information, Manufacturing Base and Competitors
Table 9. Teva Opioids Drug Major Business
Table 10. Teva Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 11. Teva SWOT Analysis
Table 12. Teva Opioids Drug Product and Services
Table 13. Teva Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Pfizer Basic Information, Manufacturing Base and Competitors
Table 15. Pfizer Opioids Drug Major Business
Table 16. Pfizer Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 17. Pfizer SWOT Analysis
Table 18. Pfizer Opioids Drug Product and Services
Table 19. Pfizer Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Amneal Pharma Basic Information, Manufacturing Base and Competitors
Table 21. Amneal Pharma Opioids Drug Major Business
Table 22. Amneal Pharma Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 23. Amneal Pharma SWOT Analysis
Table 24. Amneal Pharma Opioids Drug Product and Services
Table 25. Amneal Pharma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 27. Purdue Pharma Opioids Drug Major Business
Table 28. Purdue Pharma Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 29. Purdue Pharma SWOT Analysis
Table 30. Purdue Pharma Opioids Drug Product and Services
Table 31. Purdue Pharma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Endo Basic Information, Manufacturing Base and Competitors
Table 33. Endo Opioids Drug Major Business
Table 34. Endo Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 35. Endo SWOT Analysis
Table 36. Endo Opioids Drug Product and Services
Table 37. Endo Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 39. Mallinckrodt Opioids Drug Major Business
Table 40. Mallinckrodt Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 41. Mallinckrodt SWOT Analysis
Table 42. Mallinckrodt Opioids Drug Product and Services
Table 43. Mallinckrodt Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Mylan Basic Information, Manufacturing Base and Competitors
Table 45. Mylan Opioids Drug Major Business
Table 46. Mylan Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 47. Mylan SWOT Analysis
Table 48. Mylan Opioids Drug Product and Services
Table 49. Mylan Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. J&J Basic Information, Manufacturing Base and Competitors
Table 51. J&J Opioids Drug Major Business
Table 52. J&J Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 53. J&J SWOT Analysis
Table 54. J&J Opioids Drug Product and Services
Table 55. J&J Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Collegium Basic Information, Manufacturing Base and Competitors
Table 57. Collegium Opioids Drug Major Business
Table 58. Collegium Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 59. Collegium SWOT Analysis
Table 60. Collegium Opioids Drug Product and Services
Table 61. Collegium Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. INSYS Basic Information, Manufacturing Base and Competitors
Table 63. INSYS Opioids Drug Major Business
Table 64. INSYS Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 65. INSYS SWOT Analysis
Table 66. INSYS Opioids Drug Product and Services
Table 67. INSYS Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Hikma Basic Information, Manufacturing Base and Competitors
Table 69. Hikma Opioids Drug Major Business
Table 70. Hikma Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 71. Hikma SWOT Analysis
Table 72. Hikma Opioids Drug Product and Services
Table 73. Hikma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Egalet Basic Information, Manufacturing Base and Competitors
Table 75. Egalet Opioids Drug Major Business
Table 76. Egalet Opioids Drug Total Revenue (USD Million) (2018-2019)
Table 77. Egalet SWOT Analysis
Table 78. Egalet Opioids Drug Product and Services
Table 79. Egalet Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Global Opioids Drug Sales by Manufacturer (2018-2019) (M Units)
Table 81. Global Opioids Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 82. Global Opioids Drug Sales by Regions (2015-2020) (M Units)
Table 83. Global Opioids Drug Sales Market Share by Regions (2015-2020)
Table 84. Global Opioids Drug Revenue by Regions (2015-2020) (USD Million)
Table 85. North America Opioids Drug Sales by Countries (2015-2020) (M Units)
Table 86. North America Opioids Drug Sales Market Share by Countries (2015-2020)
Table 87. North America Opioids Drug Revenue by Countries (2015-2020) (USD Million)
Table 88. North America Opioids Drug Revenue Market Share by Countries (2015-2020)
Table 89. Europe Opioids Drug Sales by Countries (2015-2020) (M Units)
Table 90. Europe Opioids Drug Sales Market Share by Countries (2015-2020)
Table 91. Europe Opioids Drug Revenue by Countries (2015-2020) (USD Million)
Table 92. Asia-Pacific Opioids Drug Sales by Regions (2015-2020) (M Units)
Table 93. Asia-Pacific Opioids Drug Sales Market Share by Regions (2015-2020)
Table 94. Asia-Pacific Opioids Drug Revenue by Regions (2015-2020) (USD Million)
Table 95. South America Opioids Drug Sales by Countries (2015-2020) (M Units)
Table 96. South America Opioids Drug Sales Market Share by Countries (2015-2020)
Table 97. South America Opioids Drug Revenue by Countries (2015-2020) (USD Million)
Table 98. South America Opioids Drug Revenue Market Share by Countries (2015-2020)
Table 99. Middle East & Africa Opioids Drug Sales by Countries (2015-2020) (M Units)
Table 100. Middle East & Africa Opioids Drug Sales Market Share by Countries (2015-2020)
Table 101. Middle East & Africa Opioids Drug Revenue by Countries (2015-2020) (USD Million)
Table 102. Middle East & Africa Opioids Drug Revenue Market Share by Countries (2015-2020)
Table 103. Global Opioids Drug Sales by Type (2015-2020) (M Units)
Table 104. Global Opioids Drug Sales Share by Type (2015-2020)
Table 105. Global Opioids Drug Revenue by Type (2015-2020) (USD Million)
Table 106. Global Opioids Drug Revenue Share by Type (2015-2020)
Table 107. Global Opioids Drug Sales by Application (2015-2020) (M Units)
Table 108. Global Opioids Drug Sales Share by Application (2015-2020)
Table 109. Global Opioids Drug Sales Forecast by Regions (2021-2025) (M Units)
Table 110. Global Opioids Drug Market Share Forecast by Regions (2021-2025)
Table 111. Global Opioids Drug Sales Forecast by Type (2021-2025) (M Units)
Table 112. Global Opioids Drug Market Share Forecast by Type (2021-2025)
Table 113. Global Opioids Drug Sales Forecast by Application (2021-2025)
Table 114. Global Opioids Drug Market Share Forecast by Application (2021-2025)
Table 115. Direct Channel Pros & Cons
Table 116. Indirect Channel Pros & Cons
Table 117. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Opioids Drug Picture
Figure 2. Global Sales Market Share of Opioids Drug by Type in 2019
Figure 3. Oxycodone Picture
Figure 4. Hydromorphone Picture
Figure 5. Codeine Picture
Figure 6. Fentanyl Picture
Figure 7. Other Picture
Figure 8. Opioids Drug Sales Market Share by Application in 2019
Figure 9. Pain Relief Picture
Figure 10. Anesthesia Picture
Figure 11. Other Picture
Figure 12. Global Opioids Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Opioids Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Opioids Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Opioids Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Opioids Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Opioids Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Opioids Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 38. Global Opioids Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Opioids Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Opioids Drug Revenue Market Share by Regions in 2018
Figure 41. North America Opioids Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Opioids Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Opioids Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Opioids Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Opioids Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Opioids Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Opioids Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Opioids Drug Sales Market Share by Countries in 2018
Figure 49. North America Opioids Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Opioids Drug Revenue Market Share by Countries in 2018
Figure 51. United States Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 52. Canada Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 53. Mexico Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 54. Europe Opioids Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Opioids Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Opioids Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 58. UK Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 59. France Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 60. Russia Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 61. Italy Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 62. Asia-Pacific Opioids Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Opioids Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Opioids Drug Revenue Market Share by Regions 2019
Figure 65. China Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 66. Japan Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 67. Korea Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 68. India Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 69. Southeast Asia Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 70. South America Opioids Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Opioids Drug Sales Market Share by Countries in 2019
Figure 72. South America Opioids Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 74. Argentina Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 75. Middle East and Africa Opioids Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Opioids Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Opioids Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Opioids Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 80. Egypt Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 81. Turkey Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 82. South Africa Opioids Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 83. Global Opioids Drug Sales and Growth Rate (2021-2025) (M Units)
Figure 84. Global Opioids Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Opioids Drug Market Forecast (2021-2025) (M Units)
Figure 86. Europe Sales Opioids Drug Market Forecast (2021-2025) (M Units)
Figure 87. Asia-Pacific Sales Opioids Drug Market Forecast (2021-2025) (M Units)
Figure 88. South America Sales Opioids Drug Market Forecast (2021-2025) (M Units)
Figure 89. Middle East & Africa Sales Opioids Drug Market Forecast (2021-2025) (M Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
CDK 4及び6阻害薬の世界市場 2020年 Market Overview The CDK 4 and 6 Inhibitor Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…- オベチコール酸薬の世界市場 2020年 Market Overview The global Obeticholic Acid Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Obeticholic Acid Drug m…
- ナルコレプシー薬の世界市場 2020年 Market Overview The Narcolepsy Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- アンカ血管炎薬の世界市場 2020年 Market Overview The global Anca Vasculitis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anca Vasculitis Drug mar…
- コクシジオイデス症薬剤の世界市場 2020年 Market Overview The global Coccidioidomycosis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Coccidioidomycosis Dr…